OMER-DECUGIS & CIE (EPA:ALODC) | Finanzwire

Basculer en Français

10429	Companies
218409	Keywords
147910	Articles
115543	Press releases

Home
Companies
OMER-DECUGIS & CIE

PRESS RELEASE

published on 07/21/2025 at 18:00, 9 months 29 days ago

H1 2024/25 results: strong growth and solid operational performance
Omer-Decugis & Cie reports strong financial results for the first half of the 2024/25 fiscal year, with sustained revenue growth of +13.4% and improved EBITDA margin at 4.6%. Continued growth momentum in Q3 2024/25

Financial Results Revenue Growth EBITDA Margin Omer-Decugis & Cie Q3 2024/25
BRIEF

published on 07/01/2025 at 18:20, 10 months 18 days ago

Half-Yearly Report on the Omer-Decugis & Cie Liquidity Contract

Liquidity Contract Gilbert Dupont Stock Market Transactions Omer-Decugis 2025 Half-Yearly Review
BRIEF

published on 06/04/2025 at 18:05, 11 months 15 days ago

Omer-Decugis & Cie expands its ripening capacities in France

Growth Rungis Omer-Decugis Sorgues Ripening
PRESS RELEASE

published on 06/04/2025 at 18:00, 11 months 15 days ago

Omer-Decugis and Cie announces expansion projects for its ripening facilities in northern and southern France, increasing its total nationwide capacity by 30,000 tons to 174,000 tons
Omer-Decugis & Cie to expand ripening capacity by 30,000 tons in France. Projects in Sorgues & Rungis to boost capacity for tropical fruits. Acquired 16 new ripening rooms

Acquisition France Omer-Decugis & Cie Ripening Capacity Tropical Fruits
BRIEF

published on 05/13/2025 at 18:05, 1 year ago

Omer-Decugis & Cie posts growth of 13.4% in the first half of 2024/25

European Market Business Strategy Growth Turnover Exotic Fruits
PRESS RELEASE

published on 05/13/2025 at 18:00, 1 year ago

Omer-Decugis and Cie continues its growth trajectory with a record H1 2024/25 revenue of EUR 140.4m, up +13.4%
Omer-Decugis & Cie reports strong Q2 performance with a +13.1% revenue increase and confirms annual targets. SIIM division drives growth. Future logistics platform planned

Revenue Increase Logistics Platform Annual Targets Omer-Decugis SIIM Division
BRIEF

published on 03/12/2025 at 18:05, 1 year 2 months ago

OMER-DECUGIS & CIE: Share buyback program approved

Share Capital Share Buyback General Meeting Authorization Omer-Decugis & Co. 2025-2026 Program
BRIEF

published on 03/10/2025 at 18:30, 1 year 2 months ago

Minutes of the General Meeting of Omer-Decugis & Cie: Dividend Approved

Dividend Resolutions General Assembly Financial Publications Omer-Decugis
BRIEF

published on 01/27/2025 at 18:05, 1 year 3 months ago

Omer-Decugis & Cie: 2023/24 annual results and outlook

Financial Results Acquisitions Growth Sustainable Strategy Omer-Decugis & Co.
PRESS RELEASE

published on 01/27/2025 at 18:00, 1 year 3 months ago

STRONG IMPROVEMENT IN 2023/24 FULL-YEAR RESULTS AND CONTINUATION OF GROWTH DYNAMICS WITH Q1 2024/25 REVENUE UP 13.6%
Omer-Decugis & Cie reports record annual revenue of €247m (+19.7%) ahead of plan. Operating performance meets targets with EBITDA of €6.7m. Net income rises sharply to €3.0m. Debt reduction continues. Q1 2024/25 sees +13.6% growth

EBITDA Annual Revenue Debt Reduction Omer-Decugis & Cie Q1 2024/25 Growth

Accesswire

Published on 05/20/2026 at 00:00, 1 hour 12 minutes ago

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Published on 05/19/2026 at 19:45, 5 hours 27 minutes ago

Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 8 hours 25 minutes ago

Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 9 hours 57 minutes ago

Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion
Published on 05/19/2026 at 15:00, 10 hours 12 minutes ago

Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer

View all ACCESSWIRE

EQS Group

Published on 05/19/2026 at 21:24, 3 hours 47 minutes ago

EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
Published on 05/19/2026 at 19:50, 5 hours 21 minutes ago

EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 5 hours 31 minutes ago

PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 6 hours 6 minutes ago

Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics
Published on 05/19/2026 at 18:56, 6 hours 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/19/2026 at 18:45, 6 hours 27 minutes ago

Closing of the sale of Novacel
Published on 05/19/2026 at 18:34, 6 hours 37 minutes ago

Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 17:45, 7 hours 27 minutes ago

EURAZEO INVESTS IN NEXTRON SYSTEMS, A GERMAN CYBERSECURITY COMPANY SPECIALISED IN THREAT INTELLIGENCE AND CYBER FORENSICS
Published on 05/18/2026 at 22:25, 1 day 2 hours ago

Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
Published on 05/18/2026 at 18:00, 1 day 7 hours ago

Covivio Hotels - Covivio continues its expansion in hospitality in Southern Europe with a new acquisition in Torremolinos, Spain

View all LES ECHOS COMFI WIRE